{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:09:07Z","timestamp":1771348147230,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24H00628"],"award-info":[{"award-number":["JP24H00628"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K19405"],"award-info":[{"award-number":["JP21K19405"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K07211"],"award-info":[{"award-number":["JP22K07211"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K18264"],"award-info":[{"award-number":["JP23K18264"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H00528"],"award-info":[{"award-number":["JP20H00528"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23ama221505h0002"],"award-info":[{"award-number":["23ama221505h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ama221531h0001"],"award-info":[{"award-number":["24ama221531h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23ama221514h002"],"award-info":[{"award-number":["23ama221514h002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21ck0106531"],"award-info":[{"award-number":["JP21ck0106531"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22ama221514h0001"],"award-info":[{"award-number":["22ama221514h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["25ama221531h0002"],"award-info":[{"award-number":["25ama221531h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002724","name":"Child Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004094","name":"The Kyoto University Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004632","name":"The Mother and Child Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004632","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017102","name":"Friends of Leukemia Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005683","name":"Kyoto University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xcrm.2025.102576","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:37:11Z","timestamp":1769182631000},"page":"102576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CAR-T cells with the CD38-CD73-Tim-3-HLA-DR+ phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1846-4500","authenticated-orcid":false,"given":"Takashi","family":"Mikami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-4960","authenticated-orcid":false,"given":"Itaru","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara Anais","family":"Llamas-Covarrubias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidefumi","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Uchihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Mitsuyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Kitawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Saida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutsugu","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Badger","family":"Wing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Takita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102576_bib1","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1200\/JCO.2015.64.6364","article-title":"Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group","volume":"34","author":"Pieters","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102576_bib2","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1002\/cncr.30899","article-title":"Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD-2 study","volume":"123","author":"Tai","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2025.102576_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.24.00811","article-title":"JCCG ALL-B12: Evaluation of Intensified Therapies With Vincristine\/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALL","volume":"43","author":"Kato","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102576_bib4","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group","volume":"30","author":"Hunger","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102576_bib5","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102576_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31319","article-title":"Outcomes in children with first-relapsed acute lymphoblastic leukemia in Japan: Results from JCCG Study JPLSG-ALL-R08","volume":"71","author":"Yamanaka","year":"2024","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.xcrm.2025.102576_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2025.102576_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102576_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102576_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.HS9.0000843344.19780.98","article-title":"S112: Tisagenlecleucel in Pediatric and Young Adult Patients (PTS) WITH Relapsed\/Refractory (R\/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL): Final Analyses From the Eliana Study","volume":"6","author":"Rives","year":"2022","journal-title":"HemaSphere"},{"key":"10.1016\/j.xcrm.2025.102576_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jtct.2024.11.016","article-title":"Real-world Outcomes of Commercial Tisagenlecleucel for Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia in Japan","volume":"31","author":"Kato","year":"2025","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.xcrm.2025.102576_bib12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.2022016937","article-title":"How I use risk factors for success or failure of CD19 CAR T cells to guide management of children and AYA with B-cell ALL","volume":"141","author":"Myers","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102576_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12943-023-01783-1","article-title":"Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies","volume":"22","author":"Huang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2025.102576_bib14","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/s41591-022-01959-0","article-title":"Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma","volume":"28","author":"Haradhvala","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102576_bib15","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1158\/2159-8290.CD-20-1677","article-title":"Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell Therapy","volume":"11","author":"Chen","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102576_bib16","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI125423","article-title":"CD19 CAR T cell product and disease attributes predict leukemia remission durability","volume":"129","author":"Finney","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102576_bib17","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1158\/2159-8290.CD-21-1586","article-title":"Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin Lymphoma","volume":"12","author":"Jackson","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102576_bib18","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.22.00642","article-title":"Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed\/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial","volume":"41","author":"Laetsch","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102576_bib19","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1200\/JCO.21.01405","article-title":"Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL","volume":"40","author":"Myers","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102576_bib20","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1182\/bloodadvances.2019000692","article-title":"CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy","volume":"3","author":"Pillai","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2025.102576_bib21","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1200\/JCO.20.03585","article-title":"Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report","volume":"40","author":"Schultz","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102576_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.omtm.2020.12.002","article-title":"Monitoring of tisagenlecleucel transgene DNA using a quantitative polymerase chain reaction assay","volume":"20","author":"Davis","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.xcrm.2025.102576_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.21105\/joss.00861","article-title":"UMAP: Uniform Manifold Approximation and Projection","volume":"3","author":"Leland","year":"2018","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.xcrm.2025.102576_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nm.4241","article-title":"T memory stem cells in health and disease","volume":"23","author":"Gattinoni","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102576_bib25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.12688\/f1000research.11622.1","article-title":"CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets","volume":"6","author":"Nowicka","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.xcrm.2025.102576_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s42003-019-0415-5","article-title":"diffcyt: Differential discovery in high-dimensional cytometry via high-resolution clustering","volume":"2","author":"Weber","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.xcrm.2025.102576_bib27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cels.2018.02.010","article-title":"Compensation of Signal Spillover in Suspension and Imaging Mass Cytometry","volume":"6","author":"Chevrier","year":"2018","journal-title":"Cell Syst."},{"key":"10.1016\/j.xcrm.2025.102576_bib28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102576_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715234","article-title":"CD8(+) T Cell Exhaustion in Cancer","volume":"12","author":"Dolina","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102576_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103941","article-title":"Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion","volume":"77","author":"Gumber","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2025.102576_bib31","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1158\/1078-0432.CCR-22-0164","article-title":"Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma","volume":"28","author":"Monfrini","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102576_bib32","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26246","article-title":"A CD38\/CD203a\/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes","volume":"2","author":"Horenstein","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2025.102576_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00925","article-title":"Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function","volume":"10","author":"Vigano","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102576_bib34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccell.2024.01.002","article-title":"Inosine induces stemness features in CAR-T cells and enhances potency","volume":"42","author":"Klysz","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102576_bib35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.leukres.2008.07.023","article-title":"Hypersensitivity of Ph-positive lymphoid cell lines to rapamycin: Possible clinical application of mTOR inhibitor","volume":"33","author":"Hirase","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.xcrm.2025.102576_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.omto.2020.05.013","article-title":"Direct Delivery of piggyBac CD19 CAR T Cells Has Potent Anti-tumor Activity against ALL Cells in CNS in a Xenograft Mouse Model","volume":"18","author":"Tanaka","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.xcrm.2025.102576_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2015.40","article-title":"Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA","volume":"1","author":"Bai","year":"2015","journal-title":"Cell Discov."},{"key":"10.1016\/j.xcrm.2025.102576_bib38","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/eji.201343812","article-title":"PI3Kgamma kinase activity is required for optimal T-cell activation and differentiation","volume":"43","author":"Ladygina","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102576_bib39","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.4049\/jimmunol.179.11.7233","article-title":"Cbl-b regulates antigen-induced TCR down-regulation and IFN-gamma production by effector CD8 T cells without affecting functional avidity","volume":"179","author":"Shamim","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102576_bib40","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102576_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40246-024-00651-3","article-title":"Integrated multiomics revealed adenosine signaling predict immunotherapy response and regulate tumor ecosystem of melanoma","volume":"18","author":"Xu","year":"2024","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.xcrm.2025.102576_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1003512","article-title":"A prognostic signature based on adenosine metabolism related genes for ovarian cancer","volume":"12","author":"Liang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2025.102576_bib43","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41586-024-07762-w","article-title":"Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remission","volume":"634","author":"Bai","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102576_bib44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102576_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113395","article-title":"CD38: An important regulator of T cell function","volume":"153","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.xcrm.2025.102576_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104347","article-title":"Functional assessment of the cell-autonomous role of NADase CD38 in regulating CD8(+) T cell exhaustion","volume":"25","author":"Ma","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2025.102576_bib47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaci.2023.07.008","article-title":"Frequency of HLA-DR+CD38hi T cells identifies and quantifies T-cell activation in hemophagocytic lymphohistiocytosis, hyperinflammation, and immune regulatory disorders","volume":"153","author":"Nguyen","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.xcrm.2025.102576_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004089","article-title":"Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy","volume":"10","author":"Augustin","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2025.102576_bib49","article-title":"Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function","volume":"32","author":"Veliz","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.xcrm.2025.102576_bib50","article-title":"Inhibition of CD38 enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism","volume":"5","author":"Huang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2025.102576_bib51","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148546","article-title":"Targeting memory T cell metabolism to improve immunity","volume":"132","author":"Corrado","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102576_bib52","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1016\/j.cell.2021.11.016","article-title":"An NK-like CAR T cell transition in CAR T cell dysfunction","volume":"184","author":"Good","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102576_bib53","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41590-021-00975-5","article-title":"Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation","volume":"22","author":"Abdel-Hakeem","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102576_bib54","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41590-021-00979-1","article-title":"Epigenetic scars of CD8(+) T cell exhaustion persist after cure of chronic infection in humans","volume":"22","author":"Yates","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102576_bib55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41590-020-00817-w","article-title":"Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection","volume":"22","author":"Hensel","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102576_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104810","article-title":"A web-based integrative transcriptome analysis, RNAseqChef, uncovers the cell\/tissue type-dependent action of sulforaphane","volume":"299","author":"Etoh","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.102576_bib57","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102576_bib58","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","article-title":"FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data","volume":"87","author":"Van Gassen","year":"2015","journal-title":"Cytometry. A."},{"key":"10.1016\/j.xcrm.2025.102576_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2025.102576_bib60","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2025.102576_bib61","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2025.102576_bib62","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102576_bib63","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1016\/j.csbj.2021.10.020","article-title":"ggVolcanoR: A Shiny app for customizable visualization of differential expression datasets","volume":"19","author":"Mullan","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125006494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125006494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:14:29Z","timestamp":1771344869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125006494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2666379125006494"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102576","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CAR-T cells with the CD38-CD73-Tim-3-HLA-DR+ phenotype predict the efficacy of tisagenlecleucel as a treatment for B cell precursor ALL","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102576"}}